Clinical Trials Browser

Phase 2 × Nasopharyngeal Neoplasms × Bortezomib × Clear all

NCT00305734 2013-01-25

Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer

Phase 2 Completed

Nasopharyngeal Neoplasms